Peptide record

TPDB05642

Antibacterial Antifungal Toxicity standard
8 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05642
Antibacterial Antifungal Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CAFPdb
standard
No
A 8-aa standard natural multi-activity (Antibacterial, Antifungal, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
RIWVIWRR
Physicochemical Analysis
C57H89N19O9
ANDCEQGHLKMFPSTY
R
1184.46
12.70
3
0
5
+3
-1.82
-0.262
133.75
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
11000
928.70
0
Residue Composition
number
0
A
3
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
2
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 2 Y: 0 V: 1
Chemical Descriptors
8
C57H89N19O9
1184.46
12.70
+3
-1.82
-0.262
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
8 µM

Target

Pseudomonas aeruginosa H103

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against P. aeruginosa H103 (MIC 8 uM), E. coli (MIC 2 uM), S. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus
Evidence 2 Activity

Activity

MIC
Antibacterial
2 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

active against P. aeruginosa H103 (MIC 8 uM), E. coli (MIC 2 uM), S. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM
Evidence 3 Activity

Activity

MIC
Antibacterial
8 µM

Target

S. Typhimurium

Source & Reference

dbAMP DRAMP

Other

gainst P. aeruginosa H103 (MIC 8 uM), E. coli (MIC 2 uM), S. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis A
Evidence 4 Activity

Activity

MIC
Antibacterial
2 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

dbAMP DRAMP

Other

MIC 8 uM), E. coli (MIC 2 uM), S. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis ATCC29212 (MIC 8 uM), and C. albi
Evidence 5 Activity

Activity

MIC
Antibacterial
4 µM

Target

Staphylococcus epidermidis clinical strain

Source & Reference

dbAMP DRAMP

Other

. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis ATCC29212 (MIC 8 uM), and C. albicans (MIC 16 uM).
Evidence 6 Activity

Activity

MIC
Antibacterial
8 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

dbAMP DRAMP

Other

um (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis ATCC29212 (MIC 8 uM), and C. albicans (MIC 16 uM).
Evidence 7 Activity

Activity

MIC
Antibacterial
16 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

C 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis ATCC29212 (MIC 8 uM), and C. albicans (MIC 16 uM).
Evidence 8 Activity

Activity

MIC
Antifungal
8 µM

Target

Pseudomonas aeruginosa H103

Source & Reference

dbAMP DRAMP CAFPdb

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against P. aeruginosa H103 (MIC 8 uM), E. coli (MIC 2 uM), S. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus
Evidence 9 Activity

Activity

MIC
Antifungal
2 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb

Other

active against P. aeruginosa H103 (MIC 8 uM), E. coli (MIC 2 uM), S. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM
Evidence 10 Activity

Activity

MIC
Antifungal
8 µM

Target

S. Typhimurium

Source & Reference

dbAMP DRAMP CAFPdb

Other

gainst P. aeruginosa H103 (MIC 8 uM), E. coli (MIC 2 uM), S. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis A
Evidence 11 Activity

Activity

MIC
Antifungal
2 µM

Target

Staphylococcus aureus ATCC25923

Source & Reference

dbAMP DRAMP CAFPdb

Other

MIC 8 uM), E. coli (MIC 2 uM), S. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis ATCC29212 (MIC 8 uM), and C. albi
Evidence 12 Activity

Activity

MIC
Antifungal
4 µM

Target

Staphylococcus epidermidis clinical strain

Source & Reference

dbAMP DRAMP CAFPdb

Other

. enterica ssp. Typhimurium or S. Typhimurium (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis ATCC29212 (MIC 8 uM), and C. albicans (MIC 16 uM).
Evidence 13 Activity

Activity

MIC
Antifungal
8 µM

Target

Enterococcus faecalis ATCC29212

Source & Reference

dbAMP DRAMP CAFPdb

Other

um (MIC 8 uM). S. aureus ATCC25923 (MIC 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis ATCC29212 (MIC 8 uM), and C. albicans (MIC 16 uM).
Evidence 14 Activity

Activity

MIC
Antifungal
16 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb

Other

C 2 uM), S. epidermidis clinical strain (MIC 4 uM), E. faecalis ATCC29212 (MIC 8 uM), and C. albicans (MIC 16 uM).
Evidence 15 Activity

Activity

0% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
0% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Fungicidal mechanisms of the antimicrobial peptide Bac8c. | Biochim Biophys Acta | 2015
Evidence 16 Activity

Activity

10% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides. | Antimicrob Agents Chemother | 2015